These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Current concepts and new developments in the treatment of psoriatic arthritis. Pipitone N; Kingsley GH; Manzo A; Scott DL; Pitzalis C Rheumatology (Oxford); 2003 Oct; 42(10):1138-48. PubMed ID: 12810935 [TBL] [Abstract][Full Text] [Related]
5. The actual role of therapy with traditional disease-modifying antirheumatic drugs in psoriatic arthritis. Soriano ER J Rheumatol Suppl; 2012 Jul; 89():67-70. PubMed ID: 22751597 [TBL] [Abstract][Full Text] [Related]
6. Treatment strategies for early psoriatic arthritis. Olivieri I; D'Angelo S; Palazzi C; Padula A Expert Opin Pharmacother; 2009 Feb; 10(2):271-82. PubMed ID: 19236198 [TBL] [Abstract][Full Text] [Related]
8. Psoriatic arthritis therapy: NSAIDs and traditional DMARDs. Nash P; Clegg DO Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii74-7. PubMed ID: 15708943 [TBL] [Abstract][Full Text] [Related]
9. Psoriatic arthritis: current therapy and future approaches. Huynh D; Kavanaugh A Rheumatology (Oxford); 2015 Jan; 54(1):20-8. PubMed ID: 25125588 [TBL] [Abstract][Full Text] [Related]
10. Resistant cases of psoriatic arthritis: how to manage them. Atzeni F; Sarzi-Puttini P; Vena GA J Rheumatol Suppl; 2009 Aug; 83():73-5. PubMed ID: 19661549 [TBL] [Abstract][Full Text] [Related]
11. Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions. Helliwell PS; Taylor WJ; J Rheumatol; 2008 Mar; 35(3):472-6. PubMed ID: 18203324 [TBL] [Abstract][Full Text] [Related]
12. Management of Psoriatic Arthritis: Traditional Disease-Modifying Rheumatic Agents and Targeted Small Molecules. Soriano ER Rheum Dis Clin North Am; 2015 Nov; 41(4):711-22. PubMed ID: 26476228 [TBL] [Abstract][Full Text] [Related]
13. Cytokines as therapeutic targets in rheumatoid arthritis and other inflammatory diseases. Siebert S; Tsoukas A; Robertson J; McInnes I Pharmacol Rev; 2015; 67(2):280-309. PubMed ID: 25697599 [TBL] [Abstract][Full Text] [Related]
14. Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis. Bansback NJ; Ara R; Barkham N; Brennan A; Fraser AD; Conway P; Reynolds A; Emery P Rheumatology (Oxford); 2006 Aug; 45(8):1029-38. PubMed ID: 16782734 [TBL] [Abstract][Full Text] [Related]
15. Biological therapies in the spondyloarthritides--the current state. Braun J; Sieper J Rheumatology (Oxford); 2004 Sep; 43(9):1072-84. PubMed ID: 15187239 [TBL] [Abstract][Full Text] [Related]
16. Psoriatic arthritis treatment: biological response modifiers. Mease PJ; Antoni CE Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii78-82. PubMed ID: 15708944 [TBL] [Abstract][Full Text] [Related]